Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 1
1961 1
1962 8
1963 4
1964 1
1966 1
1967 7
1968 8
1969 3
1970 3
1971 3
1972 7
1973 13
1974 9
1975 11
1976 5
1977 12
1978 13
1979 16
1980 11
1981 13
1982 12
1983 11
1984 19
1985 12
1986 13
1987 17
1988 26
1989 26
1990 35
1991 27
1992 37
1993 21
1994 17
1995 34
1996 30
1997 24
1998 37
1999 46
2000 30
2001 36
2002 40
2003 39
2004 59
2005 49
2006 39
2007 50
2008 46
2009 49
2010 52
2011 74
2012 86
2013 77
2014 81
2015 71
2016 69
2017 79
2018 85
2019 79
2020 79
2021 84
2022 94
2023 86
2024 73

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,019 results

Results by year

Filters applied: . Clear all
Page 1
Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer.
Mizuta H, Okada K, Araki M, Adachi J, Takemoto A, Kutkowska J, Maruyama K, Yanagitani N, Oh-Hara T, Watanabe K, Tamai K, Friboulet L, Katayama K, Ma B, Sasakura Y, Sagae Y, Kukimoto-Niino M, Shirouzu M, Takagi S, Simizu S, Nishio M, Okuno Y, Fujita N, Katayama R. Mizuta H, et al. Among authors: katayama k. Nat Commun. 2021 Feb 24;12(1):1261. doi: 10.1038/s41467-021-21396-w. Nat Commun. 2021. PMID: 33627640 Free PMC article.
Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Sekine A, Hidaka S, Moriyama T, Shikida Y, Shimazu K, Ishikawa E, Uchiyama K, Kataoka H, Kawano H, Kurashige M, Sato M, Suwabe T, Nakatani S, Otsuka T, Kai H, Katayama K, Makabe S, Manabe S, Shimabukuro W, Nakanishi K, Nishio S, Hattanda F, Hanaoka K, Miura K, Hayashi H, Hoshino J, Tsuchiya K, Mochizuki T, Horie S, Narita I, Muto S. Sekine A, et al. Among authors: katayama k. J Clin Med. 2022 Nov 3;11(21):6528. doi: 10.3390/jcm11216528. J Clin Med. 2022. PMID: 36362756 Free PMC article. Review.
Paget-Schroetter syndrome.
Ishizuka K, Katayama K, Kaji Y, Tawara J, Ohira Y. Ishizuka K, et al. Among authors: katayama k. QJM. 2022 Jan 21;115(1):54-55. doi: 10.1093/qjmed/hcab293. QJM. 2022. PMID: 34865158 No abstract available.
Madelung Disease.
Tawara J, Ishizuka K, Enomoto K, Kamata M, Katayama K, Kaji Y, Ohira Y. Tawara J, et al. Among authors: katayama k. Am J Med. 2022 Jul;135(7):e214-e215. doi: 10.1016/j.amjmed.2022.02.028. Epub 2022 Mar 13. Am J Med. 2022. PMID: 35296399 No abstract available.
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.
Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group. Misawa S, et al. Among authors: katayama k. Lancet Neurol. 2018 Jun;17(6):519-529. doi: 10.1016/S1474-4422(18)30114-5. Epub 2018 Apr 21. Lancet Neurol. 2018. PMID: 29685815 Clinical Trial.
DOCK2 is involved in the host genetics and biology of severe COVID-19.
Namkoong H, Edahiro R, Takano T, Nishihara H, Shirai Y, Sonehara K, Tanaka H, Azekawa S, Mikami Y, Lee H, Hasegawa T, Okudela K, Okuzaki D, Motooka D, Kanai M, Naito T, Yamamoto K, Wang QS, Saiki R, Ishihara R, Matsubara Y, Hamamoto J, Hayashi H, Yoshimura Y, Tachikawa N, Yanagita E, Hyugaji T, Shimizu E, Katayama K, Kato Y, Morita T, Takahashi K, Harada N, Naito T, Hiki M, Matsushita Y, Takagi H, Aoki R, Nakamura A, Harada S, Sasano H, Kabata H, Masaki K, Kamata H, Ikemura S, Chubachi S, Okamori S, Terai H, Morita A, Asakura T, Sasaki J, Morisaki H, Uwamino Y, Nanki K, Uchida S, Uno S, Nishimura T, Ishiguro T, Isono T, Shibata S, Matsui Y, Hosoda C, Takano K, Nishida T, Kobayashi Y, Takaku Y, Takayanagi N, Ueda S, Tada A, Miyawaki M, Yamamoto M, Yoshida E, Hayashi R, Nagasaka T, Arai S, Kaneko Y, Sasaki K, Tagaya E, Kawana M, Arimura K, Takahashi K, Anzai T, Ito S, Endo A, Uchimura Y, Miyazaki Y, Honda T, Tateishi T, Tohda S, Ichimura N, Sonobe K, Sassa CT, Nakajima J, Nakano Y, Nakajima Y, Anan R, Arai R, Kurihara Y, Harada Y, Nishio K, Ueda T, Azuma M, Saito R, Sado T, Miyazaki Y, Sato R, Haruta Y, Nagasaki T, Yasui Y, Hasegawa Y, Mutoh Y, Kimura T, Sato T, Takei R, Hagi… See abstract for full author list ➔ Namkoong H, et al. Among authors: katayama k. Nature. 2022 Sep;609(7928):754-760. doi: 10.1038/s41586-022-05163-5. Epub 2022 Aug 8. Nature. 2022. PMID: 35940203 Free PMC article.
Type VI collagen-related nephropathy.
Mori M, Katayama K, Joh K, Ishikawa E, Dohi K. Mori M, et al. Among authors: katayama k. Clin Kidney J. 2022 May 5;16(1):195-196. doi: 10.1093/ckj/sfac126. eCollection 2023 Jan. Clin Kidney J. 2022. PMID: 36726445 Free PMC article. No abstract available.
Acyl-lipid metabolism.
Li-Beisson Y, Shorrosh B, Beisson F, Andersson MX, Arondel V, Bates PD, Baud S, Bird D, Debono A, Durrett TP, Franke RB, Graham IA, Katayama K, Kelly AA, Larson T, Markham JE, Miquel M, Molina I, Nishida I, Rowland O, Samuels L, Schmid KM, Wada H, Welti R, Xu C, Zallot R, Ohlrogge J. Li-Beisson Y, et al. Among authors: katayama k. Arabidopsis Book. 2013;11:e0161. doi: 10.1199/tab.0161. Epub 2013 Jan 29. Arabidopsis Book. 2013. PMID: 23505340 Free PMC article.
2,019 results